Health Equity FlexGrant

Announcing a limited grant opportunity to support pediatric medical device innovators who are focused on addressing health inequities in pediatrics through their technology. The CDC defines Health Equity as a person’s “opportunity to attain his or her full health potential, and no one is disadvantaged from achieving this potential because of social position or other socially determined circumstances."

The proposed solution can focus on any factor that impacts health equity, including but not limited to:

1. Social determinants of health, including race/ethnicity, socioeconomic status, built environment, education, employment status, etc.
2. Disease states that disproportionately impact underserved communities
3. Business models that ensure equitable access to and distribution of the technology
   

Companies will be awarded grants up to $10,000 to support activities that apply or adapt their existing medical device to help address health inequities in children. Medical devices with adult indications that are expanding or wish to expand their clinical indication to pediatrics are welcome to apply.

‍

submit your application

You will need to attach a company executive summary (max 2 pages) and/or pitch deck (max 25 slides) and a proposal of how you will utilize your medical device to help address health inequity(ies) in children.

Evaluation

Proposals will be evaluated on the following criteria:

• Clear definition of the health inequity(ies) your solution proposes to address
• How your solution will address pediatric health inequity(ies)
• Scientific, technical, engineering merit
• Clinical merit
• Feasibility of achieving stated goals with requested funding
• Sustainability of both the proposed solution and the team

To help you put together your proposal, we have curated some resources listed below.

‍

Award & Post-Award Responsibilities

• Reporting: The grantee will be expected to provide a quarterly progress report every three months after the start date of the projects. The reports will include both work progress and funds encumbered. At the conclusion of the grant, a Final Report must be submitted. Further details regarding reporting will be included in the award package.
  

Disclosure Terms and Conditions

This is a grant, not a loan or investment for equity. CTIP acknowledges that the submission of this application does not grant CTIP any rights to the work and any accompanying intellectual property is owned by the submitter. All rights to inventions, whether patentable or not, conceived or first actually reduced to practice by one or more applicants will belong to the submitter. Inventorship is decided between and among the team members involved with a given invention. Team members agree to negotiate in good faith the disposition of joint invention. The submitter acknowledges that material submitted for review by CTIP for which the submitter requests support is their own work or is submitted with permission from the entity that has legal rights to the material. CTIP may use the submitter‘s name, the submitter‘s institution, the project name the project description and associated brand assets for, including but not limited to, CTIP‘s internal tracking, record keeping, branding, website, press releases and social media presence, as well as to comply with reporting requirements mandated by the FDA (as part of our contractual obligation).